CLINICAL ROLE -
New Drug Approved by FDA for Treatment of Seizures Associated with Dravet Syndrome
Officials with the FDA have approved stiripentol (Diacomit) for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.
Read More
FDA OKs Expanded Keytruda Indication for Non-Small Cell Lung Cancer
Pembrolizumab in combination with chemotherapy reduced the risk of death by half in patients with metastatic, non-squamous non-small cell lung cancer compared with chemotherapy alone.
Expert Panel Recommends Limiting Opioid Prescribing Based on Type of Operation
An expert panel of health care providers and patients are recommending that opioid prescribing limits should be based on the operation performed rather than a blanket approach.
FDA Approves New Drug for Treatment of Seizures Associated With Dravet Syndrome
Officials with the FDA approved have approved stiripentol (Diacomit) for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.
Drug Shortage Prompts Expiration Date Extension for Some Epinephrine Products
The FDA said that it has extended expiration dates on some EpiPen and generic versions, all manufactured by Pfizer, by 4 months.
Exploring the Path of the Specialty DollarÂ
Understanding specialty drug pricing, and the flow of health care dollars through the lens of the stakeholders involved.
Follicular Lymphoma Survival Rates Significantly Higher in Privately-Insured Patients
Privately-insured patients with follicular lymphoma (FL) have nearly 2-fold better survival outcomes compared with publicly-insured or non-insured patients, according to a new study.
Older Adults, Hispanics Less Likely to Receive HIV Testing
Interventions must address HIV testing and beliefs among both patients and providers in order to reach underserved populations.
Alzheimer Disease Risk Linked to Use of Benzodiazepines, Related Z-drugs
The use of benzodiazepines and related z-drugs was found to be associated with a modest increase in the risk of Alzheimer disease in a case-control trial.
Trending News Today: Anthem, Walmart Partner to Launch OTC Drug Program
Top news of the day from across the health care landscape.
Trending News Today: US Childhood Cancer Survival Rates Tied to Socioeconomic Status
Pharmacy Students: Stop Trying to Decide What to Be When You Grow Up
Pharmacy students should take the pressure off themselves and think about their next steps, not the rest of their careers.
MS Therapy Disrupts B-Cell Infiltration, Aggregate Formation in CNS
Study evaluates the effect of multiple sclerosis treatment alemtuzumab (Lemtrada) on the B-cell component of MS.
Expert Panel: Opioid Prescribing Limits Should be Based on Operation Performed
The prescribing limits are designed to help prevent patients from receiving unnecessary opioid pills after surgery.
CDC: Poor Contact Lens Hygiene Increases Risk of Infection
The CDC is Partnering with the American Optometric Association to bring inform patients about proper lens care, during Contact Lens Awareness Week.
Insurance Status Associated with Patient Survival in Follicular Lymphoma
New study finds that privately-insured patients with follicular lymphoma have better survival outcomes.
Persistent Use of Osteoporosis Drugs Associated with Reduced Health Costs
Persistent use of osteoporosis medications was associated with reduced risk of fracture and significantly lower total healthcare costs, a recent analysis of Medicare claims data found.
FDA Permits Marketing of Stimulation Device for Treatment of Obsessive Compulsive Disorder
Officials with the FDA have given approval for marketing Brainsway’s Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder.
Expanded Hepatitis C Testing in Emergency Departments Shows Success
Testing individuals not considered high-risk for hepatitis C virus addresses increase in new infections associated with opioid epidemic.
Novel Cystic Fibrosis Treatment Reduces Frequency of Exacerbations in Phase 2 Study
Celtaxsys’ acebilustat is the first novel anti-inflammatory molecule with the potential to both reduce pulmonary exacerbations and prolong time to first exacerbation.
Poor Prognosis Associated with Disease Progression in Rheumatoid Arthritis
The rate of disease progression in patients with rheumatoid arthritis (RA) can be associated with a poor prognosis in patients.
Trending News Today: PBMs Say Manufacturers Won't Commit to Lower Drug Prices
Trending News Today: Blood Pressure Pills Often Taken with Interfering Medications
Monday Pharmaceutical Mystery: August 20
Can you solve the pharmaceutical mystery? Each week, a new case study is presented.
Solution for Treating Dry Eye Disease Approved by FDA
Sun Pharmaceutical's cyclosporine ophthalmic solution is the first and only dry eye treatment to combine cyclosporine A with nanomicellar technology, according to the company.
First Checkpoint Inhibitor for Previously Treated Patients with SCLC Approved by FDA
With this approval, nivolumab (Opdivo) offers a new treatment option for patients with small cell lung cancer whose cancer has progressed after 2 or more prior lines of therapy.
US Life Expectancy Drops, Mortality Rises Among Younger Adults
Two new studies highlight trends in life expectancy and mortality across high-income countries, citing worsening health in the United States.
New Technology Enables Novel Use of Brain Biomarker in Multiple Sclerosis
Assessment of neurofilament light chain levels offers real-time, efficient measure marker of multiple sclerosis progression.
RA Risk Increased By Secondhand Smoke Exposure During Childhood
Childhood exposure to secondhand smoke may heighten the risk of developing rheumatoid arthritis (RA) later in life, even in non-smokers, according to new research.
Low-Income Patients With Substance Use Disorders Benefit from Medicaid Expansion
States that chose to expand Medicaid eligibility under the Affordable Care Act (ACA) have seen a greater decrease in uninsured rates among low-income patients.
